Toru
Amaya
*a,
Izumi
Kurata
a and
Toshikazu
Hirao
*ab
aDepartment of Applied Chemistry, Graduate School of Engineering, Osaka University, Yamada-oka, Suita, Osaka 565-0871, Japan. E-mail: amaya@chem.eng.osaka-u.ac.jp
bThe Institute of Scientific and Industrial Research, Osaka University, Mihoga-oka, Ibaraki, Osaka 567-0047, Japan. E-mail: hirao@chem.eng.osaka-u.ac.jp
First published on 29th June 2016
The synthesis of 3-aryl-3-hydroxy-2-oxindoles, which are a structural motif found in various natural products and pharmaceutically active compounds, was conducted via reductive coupling of (2-aminophenyl)(aryl)methanone derivatives and CO2 as a key step. The conditions employing Mg with chlorotrimethylsilane in DMA are the best for the reductive coupling, where the aryl halide moiety is intact. This reaction proceeds well without the protection of the amino group. The reductive coupling and acid-catalyzed lactam formation can be performed in a one-pot reaction to give the oxindoles.
Oxindoles are a structural motif found in various natural products and medicinally relevant molecules.2 In this study, the synthesis of 3-aryl-3-hydroxy-2-oxindoles 1 is focused on, as the skeleton is included in several pharmaceutical compounds such as SM-1306863 and ECi8.4Scheme 1a shows the representative examples of the previously reported retrosynthesis for 1. Most commonly, oxindoles 1 are synthesized via 1,2-addition of an aryl anion equivalent to an isatin derivative.5 Intramolecular arylation to a ketone is also reported.6 Another approach involves aromatic nucleophilic substitution with an enolate of mandelic acid derivatives as a key step.7 In this context, our retrosynthesis was designed based on reductive CO2 fixation with (2-aminophenyl)(aryl)methanone derivatives 2, followed by lactam formation (Scheme 1b). So far, an enormous number of synthetic reports for 1 have been published (Scheme 1b). However, to the best of our knowledge, such an approach via CO2 fixation has not been reported.
Scheme 1 (a) Representative examples of the previously reported retrosynthesis for 3-aryl-3-hydroxy-2-oxindoles 1. (b) Our retrosynthesis for 1. |
Reductive CO2 fixation of diaryl ketones has been studied.8–11 Such a reaction can be roughly classified into four reduction patterns, reduction by (1) electrodes,8 (2) alkali metals,9 (3) low-valent transition or rare-earth metals10 and (4) light.11 Our group also has developed the reductive coupling of aldehydes, especially utilizing early-transition metals such as vanadium and titanium compounds as a catalyst in the presence of chlorotrimethylsilane.12 Here, we report the synthesis of 3-aryl-3-hydroxy-2-oxindoles 1via reductive coupling of CO2 and ketoamines 2 as a key step.
Entry | Catalyst | Solvent | Yielda/% | ||
---|---|---|---|---|---|
Recovered 2ab | Oxindole 1a | Alcohol 3b | |||
a Yield was calculated by using the integral ratio of the peaks for each compound and the internal standard (1,3,5-trimethoxybenzene) in the 1H NMR spectrum of the crude mixture. b Starting substrate 2a and the byproducts 3 and 5 were present as a HCl salt in the aqueous layer with a HCl solution after the treatment with an aqueous 3 M HCl solution. To extract them from the aqueous layer, a saturated aqueous NaHCO3 solution was added, and they were extracted with ethyl acetate. c Reaction time was 20 h. d The formation of indole 4 and deoxygenated compound 5 was observed as by-products in this entry. e Not determined. | |||||
1c,d | TiCl4 | DMF | 65 | 0 | n.d.e |
2c | TiCl4 | THF | Complex mixture | ||
3c | TiCl4 | DME | Complex mixture | ||
4 | Cp2TiCl2 | DMA | 20 | 3 | 13 |
5 | VCl3 | DMA | 23 | 9 | 19 |
6 | VBr3 | DMA | 22 | 4 | 44 |
7 | Cp2VCl2 | DMA | 7 | 2 | 27 |
8 | — | DMA | 8 | 2 | 43 |
The screening was continued using Mg as a terminal reductant in DMA (Table 2). In this case, the desired oxindole 1a was obtained under the conditions with a catalyst shown in entries 1–6 in Table 2. But, the formation of alcohol 3 was observed in the presence of titanium or vanadium catalysts. Finally, the desired oxindole 1a was obtained in the absence of a catalyst in 95% yield (Table 2, entry 7).13 Decreasing the amount of chlorotrimethylsilane to 1 equivalent resulted in lowering of the yield of 1a to 70% (Table 2, entry 8). In the absence of both a catalyst and chlorotrimethylsilane, the product 1a was not detected, showing that chlorotrimethylsilane is essential (Table 2, entry 9). This is consistent with the previous results.12 Instead of chlorotrimethylsilane, the use of collidine HCl salt provided 1a in a low yield (Table 2, entry 10). Keeping the equivalents of Mg at three was not a problem (97%, Table 2, entry 11). But, the further decreasing to one equivalent gave rise to a decrease of the yield of 1a (74%, Table 2, entry 12).
Entry | Catalyst | Yielda/% | ||
---|---|---|---|---|
Recovered 2ab | Oxindole 1a | Alcohol 3b | ||
a Yield was calculated by using the integral ratio of the peaks for each compound and internal standard (1,3,5-trimethoxybenzene) in the 1H NMR spectrum of the crude mixture. b Starting substrates 2a and 3 were present as a HCl salt in the aqueous layer with a HCl solution after the treatment with an aqueous 3 M HCl solution. To extract them from the aqueous layer, a saturated aqueous NaHCO3 solution was added, and they were extracted with ethyl acetate. c It was difficult to quantify. d Instead of chlorotrimethylsilane. e Isolated yield (containing a very small amount of ethyl acetate, see the ESI for the 1H NMR spectrum). | ||||
1 | TiCl4 | —c | 44 | 11 |
2 | VCl3 | 0 | 51 | 5 |
3 | Cp2TiCl2 | 0 | 68 | 2 |
4 | Cp2VCl2 | 0 | 80 | 16 |
5 | Yb(OTf)3 | 7 | 52 | 16 |
6 | VBr3 | 0 | 52 | 21 |
7 | — | 0 | 95 | 5 |
8 | — (1 equiv. of Me3SiCl) | 16 | 70 | 7 |
9 | — (Without Me3SiCl) | 27 | 0 | 48 |
10 | — (With collidine HCl salt)d | 51 | 11 | 11 |
11 | — (3 equiv. of Mg) | 0 | 97 (99)e | Trace |
12 | — (1 equiv. of Mg) | 19 | 74 | —c |
The scope and limitation of the substrates were investigated (Scheme 2). It is important to note that aryl halides such as fluoride, chloride and bromide can be used as a substrate to give oxindoles 1 in good yields in spite of the presence of Mg (96% for 1c, 93% for 1d, 88% for 1e, 76% for 1f and 96% for 1k). The presence of an electron donating group at the para position of the phenyl group was not a problem for this reaction (85% for 1g). The ester moiety was tolerated in this reaction to afford the corresponding product 1h in 83% yield. The product 1i with a furyl group was also synthesized in this reaction. N-Methylated substrates reacted well to give the corresponding products (76% for 1j and 96% for 1k). Instead of the aryl group, the methyl group at R3 did not provide a good result, and the yield of 1i was quite low (2%).
To gain an insight into the reaction path, aqueous work-up with a basic solution (aqueous saturated NaHCO3 solution) instead of an aqueous 3 M HCl solution was carried out for the reaction of 2a. The aqueous solution was extracted with ethyl acetate. Both the organic and aqueous layers were separately treated with an aqueous 3 M HCl solution. From the aqueous layer (Scheme 3b), oxindole 1a was obtained in 64% yield, but 11% from the organic layer (Scheme 3a). These results indicate that the lactam formation in entry 7 in Table 2 and Scheme 2 mainly takes place in the process of the treatment with aqueous 3 M HCl solution.
Scheme 3 Aqueous work-up with a basic solution followed by acid treatment for the synthesis of oxindoles 1avia reductive coupling of 2a and CO2. |
Concerning the reductive coupling with CO2, there are two plausible paths (Scheme 4),13 (1) one-electron reduction of the ketone, addition of the resulting radical anion species to CO2, followed by one-electron reduction (path A) and (2) sequential two-electron reduction of the ketone and 1,2-addition of the carbanion (path B). The related papers presenting the mechanisms were also reported for both paths,9a,14,15 which cannot be excluded for this reaction at present.
1e: 1H NMR (400 MHz, DMSO-d6) δ = 10.67 (s, 1 H), 7.91 (ddd, 7.9, 7.9, 1.8 Hz, 1 H), 7.42–7.25 (m, 3 H), 7.06 (ddd, J = 11.5, 8.1, 1.1 Hz, 1 H), 7.00 (s, 1 H), 6.90 (d, J = 9.9 Hz, 1 H), 6.91 (s, 1 H) ppm; 13C NMR (100 MHz, DMSO-d6) δ = 177.05, 158.39 (d, J = 245.4 Hz), 141.25, 134.29, 129.88 (d, J = 7.7 Hz), 129.27, 128.16 (d, J = 12.5 Hz), 128.01 (d, J = 3.8 Hz), 125.68, 124.30 (d, J = 2.9 Hz), 124.09, 115.16 (d, J = 21.1 Hz), 111.29, 74.25 ppm; IR(ATR) ν = 3410, 3237, 2367, 2328, 1713, 1485, 1049, 823, 755 cm−1; HRMS(FAB) m/z: [M]+ calcd for C14H9ClFNO2: 277.0306; found: 277.0308.
1f: 1H NMR (400 MHz, DMSO-d6) δ = 10.70 (s, 1 H), 8.06 (dd, J = 7.8, 1.8 Hz, 1 H), 7.49 (ddd, J = 7.8, 7.8, 1.8 Hz 1 H), 7.41–7.32 (m, 2 H), 7.29 (dd, J = 8.2, 2.3 Hz, 1 H), 7.03 (s, 1 H), 6.89 (d, J = 8.2 Hz, 1 H), 6.76 (d, J = 2.3 Hz, 1 H) ppm; 13C NMR (100 MHz, DMSO-d6) δ = 176.45, 142.21, 137.89, 133.54, 130.28, 129.72 × 2, 129.29, 129.02, 126.89, 125.51, 123.82, 111.19, 76.07 ppm; IR(ATR) ν = 3420, 3237, 2361, 2342, 1711, 1483, 1470, 1437, 1036, 826, 746, 732 cm−1; HRMS(FAB) m/z: [M]+ calcd for C14H9Cl2NO2: 293.0010; found: 293.0008.
1h: 1H NMR (400 MHz, DMSO-d6) δ = 10.58 (s, 1 H), 7.97 (d, J = 8.7 Hz, 2 H), 7.72 (d, J = 8.7 Hz 2 H), 7.68 (dd, J = 8.2, 2.3 Hz, 1 H), 7.46 (d, J = 1.8 Hz, 1 H), 7.36–7.24 (m, 5 H), 7.04 (d, J = 8.2 Hz, 1 H), 6.75 (s, 1 H), 4.31 (q, J = 7.3 Hz, 2H), 1.32 (t, J = 7.3 Hz, 3H) ppm; 13C NMR (100 MHz, DMSO-d6) δ = 178.55, 165.63, 144.38, 142.47, 141.27, 134.76, 132.85, 129.87, 128.25, 128.13, 127.61, 126.25, 125.47, 123.18, 110.57, 77.41, 60.73, 14.23 ppm; IR(KBr) ν = 3308, 3061, 2980, 2933, 1728, 1713, 1606, 1484, 1278, 1175, 1103, 771 cm−1; HRMS(EI) m/z: [M]+ calcd for C23H19NO4: 373.1314; found: 373.1310.
1i: 1H NMR (400 MHz, DMSO-d6) δ = 10.44 (s, 1 H), 7.59 (brd, J = 1.8 Hz, 1 H), 7.30 (d, J = 7.3 Hz, 1 H), 7.24 (ddd, J = 7.8, 7.8, 0.9 Hz, 1 H), 6.98 (dd, J = 7.3, 7.3 Hz, 1 H), 6.85 (d, J = 7.3, 1 H), 6.73 (s, 1H), 6.40 (dd, J = 3.2, 1.8 Hz, 1 H), 6.30 (d, J = 3.2 Hz, 1 H) ppm; 13C NMR (100 MHz, DMSO-d6) δ = 176.18, 153.01, 143.19, 141.69, 130.78, 129.56, 124.99, 121.87, 110.27, 109.88, 107.65, 73.48 ppm; IR(KBr) ν = 3310, 2822, 2361, 1709, 1684, 1624, 1474, 1311, 1112, 763 cm−1; HRMS(EI) m/z: [M]+ calcd for C12H9NO3: 215.0582; found: 215.0583.
2h: 1H NMR (400 MHz, CDCl3) δ = 8.02 (d, J = 8.7 Hz, 2 H), 7.75 (d, J = 2.3 Hz 1 H), 7.72–7.68 (m, 2 H), 7.62 (dd, J = 8.7, 2.3 Hz, 1 H), 7.56 (tt, J = 7.3, 1.4 Hz, 1 H), 7.51–7.46 (m, 4 H), 6.85 (d, J = 8.7 Hz, 1 H), 6.20 (brs, 2 H) ppm; 13C NMR (100 MHz, CDCl3) δ = 198.89, 166.48, 150.78, 144.54, 139.77, 132.99, 132.88, 131.46, 130.13, 129.24, 128.42, 128.29, 127.25, 125.79, 118.34, 117.67, 60.88, 14.35 ppm; IR(KBr) ν = 3487, 3352, 3066, 2986, 2902, 1704, 1639, 1729, 1247, 1107, 775 cm−1; HRMS(EI) m/z: [M]+ calcd for C22H19NO3: 345.1365; found: 345.1360.
Footnotes |
† This paper is dedicated to Professor Barry M. Trost on the occasion of his 75th birthday. |
‡ Electronic supplementary information (ESI) available: 1H NMR spectrum for 1a, and 1H and 13C NMR spectra for 1d, 1e, 1f, 1h, 1i and 2h. See DOI: 10.1039/c6qo00107f |
This journal is © the Partner Organisations 2016 |